entacapone (Q416444)

From Wikidata
Jump to navigation Jump to search
one of the types of COMT inhibitors that is used for the treatment of Parkinson's disease
  • COM998
  • OR-611
  • (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide
  • N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    entacapone
    one of the types of COMT inhibitors that is used for the treatment of Parkinson's disease
    • COM998
    • OR-611
    • (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide
    • N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide

    Statements

    0 references
    305.101171 dalton
    1 reference
    C₁₄H₁₅N₃O₅
    1 reference
    CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
    1 reference
    CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N
    1 reference
    Entacapone
    0 references

    Identifiers

    8158723
    1 reference
    1 reference
    28 October 2019
    ENTACAPONE (English)
    10 May 2021
    0 references
    1 reference
    27 December 2018
    (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide (English)
    CAS no.: 130929-57-6 (English)
    1 reference
    27 December 2018
    (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide (English)
    CAS no.: 130929-57-6 (English)
    1 reference
    1 reference
    0 references
     
    edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit